Table S2.
Histone deacetylase inhibitors included in the compound library
HDAC inhibitor | Hit? | HDAC target |
Panobinostat (LBH-589) | Yes | HDAC1, HDAC2, HDAC3, HDAC6 |
AR-42 (HDAC-42) | Yes | Pan inhibitor |
Trichostatin A (TSA) | Yes | Pan inhibitor |
Vorinostat (SAHA) | Yes | HDAC1, HDAC2, HDAC3, HDAC6 |
Entinostat (MS-275) | Yes | HDAC1, HDAC2, HDAC3, HDAC9 |
Abexinostat (PCI-24781) | Yes | HDAC1, HDAC2, HDAC3, HDAC6, HDAC10 |
Dacinostat (NVP-LAQ824) | Yes | HDAC1, HDAC3, HDAC4, HDAC6 |
Quisinostat (JNJ-26481585) | Yes | Pan inhibitor |
CUDC-101 | Yes | Pan-HDAC, EGFR, HER2 |
Pracinostat (SB939) | Yes | Pan inhibitor |
Givinostat (ITF2357) | Yes | HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7 |
CUDC-907 | Yes | Pan-HDAC and PI3K |
M344 | Yes | Pan inhibitor |
Romidepsin (FK228) | Yes | HDAC1, HDAC2, HDAC3, HDAC8 |
Tubastatin HCl | No (negative control) | HDAC6 |
Belinostat (PXD101) | No | HDAC1, HDAC2, HDAC3, HDAC6 |
Mocetinostat (MGCD0103) | No | HDAC1, HDAC2 |
Droxinostat | No | HDAC3, HDAC6, HDAC8 |
MC1568 | No | HDAC4, HDAC5, HDAC7, HDAC9 |
PCI-34051 | No | HDAC8 |
Tacedinaline (CI-994) | No | HDAC1, HDAC2, HDAC3 |
Histone deacetylase inhibitors, specification of screening status, and recognized HDAC target specificity are shown.